Observational studyBlood advances2025

Targeting bone marrow mesenchymal stromal cell-derived IL-6 to overcome acute myeloid leukemia chemoresistance.

Diyu Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.